KSE - Delayed Quote KRW

Daewoong Co., Ltd. (003090.KS)

20,300.00
+50.00
+(0.25%)
At close: 3:30:30 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Yeong-Hwan Yoon Chairman and Chief Executive Officer -- -- 1934
Mr. Nan-Young Jeong Chief Executive Officer, President and Representative Director -- -- 1942

Daewoong Co., Ltd.

244 Galmachi-ro
Jungwon-gu
Seongnam
South Korea
82 2 550 8800 https://www.daewoongholdings.com
Sector: 
Healthcare

Description

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.

Corporate Governance

Daewoong Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 12, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC

Daewoong Co., Ltd. Earnings Date

Recent Events

December 27, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers